Impact of COVID-19 Outbreak on Intravenous Injection Immunoglobulin, Global Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Injection Immunoglobulin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Intravenous Injection Immunoglobulin industry.
Segment by Type, the Intravenous Injection Immunoglobulin market is segmented into
The Intravenous Injection Immunoglobulin market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Intravenous Injection Immunoglobulin market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Intravenous Injection Immunoglobulin market include:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Injection Immunoglobulin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Intravenous Injection Immunoglobulin industry.
Segment by Type, the Intravenous Injection Immunoglobulin market is segmented into
- 1g/20ml
- 1.25g/25ml
- 2.5g/50ml
- 5g/100ml
- 10g/200ml
- Hospital
- Clinic
- Others
The Intravenous Injection Immunoglobulin market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Intravenous Injection Immunoglobulin market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Intravenous Injection Immunoglobulin market include:
- Boya-Bio
- Beijing Tiantan Biological Products
- Hualan Bio
- Guangdong Shuagnlin Bio-pharmacy
- Weiguang Biological
- Sinopharm
- Shanghai RAAS
- CTBB
- Nanyue Biopharming
1 INTRAVENOUS INJECTION IMMUNOGLOBULIN MARKET OVERVIEW
1.1 Product Overview and Scope of Intravenous Injection Immunoglobulin
1.2 Covid-19 Impact on Intravenous Injection Immunoglobulin Segment by Type
1.2.1 Global Intravenous Injection Immunoglobulin Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Covid-19 Impact on Intravenous Injection Immunoglobulin Segment by Application
1.3.1 Intravenous Injection Immunoglobulin Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Covid-19 Impact on Global Intravenous Injection Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Intravenous Injection Immunoglobulin Revenue 2015-2026
1.4.2 Global Intravenous Injection Immunoglobulin Sales 2015-2026
1.4.3 Intravenous Injection Immunoglobulin Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Intravenous Injection Immunoglobulin Industry
1.7 COVID-19 Impact: Intravenous Injection Immunoglobulin Market Trends
2 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
2.2 Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
2.3 Global Intravenous Injection Immunoglobulin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Intravenous Injection Immunoglobulin Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Injection Immunoglobulin Market Competitive Situation and Trends
2.5.1 Intravenous Injection Immunoglobulin Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Intravenous Injection Immunoglobulin Players (Opinion Leaders)
3 COVID-19 IMPACT ON INTRAVENOUS INJECTION IMMUNOGLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intravenous Injection Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Intravenous Injection Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.3.1 North America Intravenous Injection Immunoglobulin Sales by Country
3.3.2 North America Intravenous Injection Immunoglobulin Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.4.1 Europe Intravenous Injection Immunoglobulin Sales by Country
3.4.2 Europe Intravenous Injection Immunoglobulin Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Injection Immunoglobulin Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region
3.5.2 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.6.1 Latin America Intravenous Injection Immunoglobulin Sales by Country
3.6.2 Latin America Intravenous Injection Immunoglobulin Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country
3.7.2 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
4.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2015-2020)
4.3 Global Intravenous Injection Immunoglobulin Price Market Share by Type (2015-2020)
4.4 Global Intravenous Injection Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
5.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2015-2020)
5.3 Global Intravenous Injection Immunoglobulin Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN INTRAVENOUS INJECTION IMMUNOGLOBULIN BUSINESS
6.1 Boya-Bio
6.1.1 Corporation Information
6.1.2 Boya-Bio Description, Business Overview and Total Revenue
6.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Boya-Bio Products Offered
6.1.5 Boya-Bio Recent Development and Response to COVID-19
6.2 Beijing Tiantan Biological Products
6.2.1 Beijing Tiantan Biological Products Corporation Information
6.2.2 Beijing Tiantan Biological Products Description, Business Overview and Total Revenue
6.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Beijing Tiantan Biological Products Products Offered
6.2.5 Beijing Tiantan Biological Products Recent Development and Response to COVID-19
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description, Business Overview and Total Revenue
6.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Hualan Bio Products Offered
6.3.5 Hualan Bio Recent Development and Response to COVID-19
6.4 Guangdong Shuagnlin Bio-pharmacy
6.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
6.4.2 Guangdong Shuagnlin Bio-pharmacy Description, Business Overview and Total Revenue
6.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Guangdong Shuagnlin Bio-pharmacy Products Offered
6.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development and Response to COVID-19
6.5 Weiguang Biological
6.5.1 Weiguang Biological Corporation Information
6.5.2 Weiguang Biological Description, Business Overview and Total Revenue
6.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Weiguang Biological Products Offered
6.5.5 Weiguang Biological Recent Development and Response to COVID-19
6.6 Sinopharm
6.6.1 Sinopharm Corporation Information
6.6.2 Sinopharm Description, Business Overview and Total Revenue
6.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sinopharm Products Offered
6.6.5 Sinopharm Recent Development and Response to COVID-19
6.7 Shanghai RAAS
6.6.1 Shanghai RAAS Corporation Information
6.6.2 Shanghai RAAS Description, Business Overview and Total Revenue
6.6.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Shanghai RAAS Products Offered
6.7.5 Shanghai RAAS Recent Development and Response to COVID-19
6.8 CTBB
6.8.1 CTBB Corporation Information
6.8.2 CTBB Description, Business Overview and Total Revenue
6.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CTBB Products Offered
6.8.5 CTBB Recent Development and Response to COVID-19
6.9 Nanyue Biopharming
6.9.1 Nanyue Biopharming Corporation Information
6.9.2 Nanyue Biopharming Description, Business Overview and Total Revenue
6.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Nanyue Biopharming Products Offered
6.9.5 Nanyue Biopharming Recent Development and Response to COVID-19
7 INTRAVENOUS INJECTION IMMUNOGLOBULIN MANUFACTURING COST ANALYSIS
7.1 Intravenous Injection Immunoglobulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
7.4 Intravenous Injection Immunoglobulin Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Intravenous Injection Immunoglobulin Distributors List
8.3 Intravenous Injection Immunoglobulin Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Intravenous Injection Immunoglobulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Type (2021-2026)
10.2 Intravenous Injection Immunoglobulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Application (2021-2026)
10.3 Intravenous Injection Immunoglobulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Region (2021-2026)
10.4 North America Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.5 Europe Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.6 Asia Pacific Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.7 Latin America Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.8 Middle East and Africa Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Intravenous Injection Immunoglobulin
1.2 Covid-19 Impact on Intravenous Injection Immunoglobulin Segment by Type
1.2.1 Global Intravenous Injection Immunoglobulin Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Covid-19 Impact on Intravenous Injection Immunoglobulin Segment by Application
1.3.1 Intravenous Injection Immunoglobulin Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Covid-19 Impact on Global Intravenous Injection Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Intravenous Injection Immunoglobulin Revenue 2015-2026
1.4.2 Global Intravenous Injection Immunoglobulin Sales 2015-2026
1.4.3 Intravenous Injection Immunoglobulin Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Intravenous Injection Immunoglobulin Industry
1.7 COVID-19 Impact: Intravenous Injection Immunoglobulin Market Trends
2 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
2.2 Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
2.3 Global Intravenous Injection Immunoglobulin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Intravenous Injection Immunoglobulin Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Injection Immunoglobulin Market Competitive Situation and Trends
2.5.1 Intravenous Injection Immunoglobulin Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Intravenous Injection Immunoglobulin Players (Opinion Leaders)
3 COVID-19 IMPACT ON INTRAVENOUS INJECTION IMMUNOGLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Intravenous Injection Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Intravenous Injection Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.3.1 North America Intravenous Injection Immunoglobulin Sales by Country
3.3.2 North America Intravenous Injection Immunoglobulin Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.4.1 Europe Intravenous Injection Immunoglobulin Sales by Country
3.4.2 Europe Intravenous Injection Immunoglobulin Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Injection Immunoglobulin Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region
3.5.2 Asia Pacific Intravenous Injection Immunoglobulin Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.6.1 Latin America Intravenous Injection Immunoglobulin Sales by Country
3.6.2 Latin America Intravenous Injection Immunoglobulin Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Intravenous Injection Immunoglobulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country
3.7.2 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
4.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2015-2020)
4.3 Global Intravenous Injection Immunoglobulin Price Market Share by Type (2015-2020)
4.4 Global Intravenous Injection Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 COVID-19 IMPACT ON GLOBAL INTRAVENOUS INJECTION IMMUNOGLOBULIN HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
5.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2015-2020)
5.3 Global Intravenous Injection Immunoglobulin Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN INTRAVENOUS INJECTION IMMUNOGLOBULIN BUSINESS
6.1 Boya-Bio
6.1.1 Corporation Information
6.1.2 Boya-Bio Description, Business Overview and Total Revenue
6.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Boya-Bio Products Offered
6.1.5 Boya-Bio Recent Development and Response to COVID-19
6.2 Beijing Tiantan Biological Products
6.2.1 Beijing Tiantan Biological Products Corporation Information
6.2.2 Beijing Tiantan Biological Products Description, Business Overview and Total Revenue
6.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Beijing Tiantan Biological Products Products Offered
6.2.5 Beijing Tiantan Biological Products Recent Development and Response to COVID-19
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description, Business Overview and Total Revenue
6.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Hualan Bio Products Offered
6.3.5 Hualan Bio Recent Development and Response to COVID-19
6.4 Guangdong Shuagnlin Bio-pharmacy
6.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
6.4.2 Guangdong Shuagnlin Bio-pharmacy Description, Business Overview and Total Revenue
6.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Guangdong Shuagnlin Bio-pharmacy Products Offered
6.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development and Response to COVID-19
6.5 Weiguang Biological
6.5.1 Weiguang Biological Corporation Information
6.5.2 Weiguang Biological Description, Business Overview and Total Revenue
6.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Weiguang Biological Products Offered
6.5.5 Weiguang Biological Recent Development and Response to COVID-19
6.6 Sinopharm
6.6.1 Sinopharm Corporation Information
6.6.2 Sinopharm Description, Business Overview and Total Revenue
6.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sinopharm Products Offered
6.6.5 Sinopharm Recent Development and Response to COVID-19
6.7 Shanghai RAAS
6.6.1 Shanghai RAAS Corporation Information
6.6.2 Shanghai RAAS Description, Business Overview and Total Revenue
6.6.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Shanghai RAAS Products Offered
6.7.5 Shanghai RAAS Recent Development and Response to COVID-19
6.8 CTBB
6.8.1 CTBB Corporation Information
6.8.2 CTBB Description, Business Overview and Total Revenue
6.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CTBB Products Offered
6.8.5 CTBB Recent Development and Response to COVID-19
6.9 Nanyue Biopharming
6.9.1 Nanyue Biopharming Corporation Information
6.9.2 Nanyue Biopharming Description, Business Overview and Total Revenue
6.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Nanyue Biopharming Products Offered
6.9.5 Nanyue Biopharming Recent Development and Response to COVID-19
7 INTRAVENOUS INJECTION IMMUNOGLOBULIN MANUFACTURING COST ANALYSIS
7.1 Intravenous Injection Immunoglobulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
7.4 Intravenous Injection Immunoglobulin Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Intravenous Injection Immunoglobulin Distributors List
8.3 Intravenous Injection Immunoglobulin Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Intravenous Injection Immunoglobulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Type (2021-2026)
10.2 Intravenous Injection Immunoglobulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Application (2021-2026)
10.3 Intravenous Injection Immunoglobulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Injection Immunoglobulin by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Intravenous Injection Immunoglobulin by Region (2021-2026)
10.4 North America Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.5 Europe Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.6 Asia Pacific Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.7 Latin America Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
10.8 Middle East and Africa Intravenous Injection Immunoglobulin Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Intravenous Injection Immunoglobulin Sales (L) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Intravenous Injection Immunoglobulin Sales (L) Comparison by Application: 2020 VS 2026
Table 3. Global Intravenous Injection Immunoglobulin Market Size by Type (L) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Intravenous Injection Immunoglobulin Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Intravenous Injection Immunoglobulin Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Intravenous Injection Immunoglobulin Players to Combat Covid-19 Impact
Table 9. Global Key Intravenous Injection Immunoglobulin Manufacturers Covered in This Study
Table 10. Global Intravenous Injection Immunoglobulin Sales (L) by Manufacturers (2015-2020)
Table 11. Global Intravenous Injection Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 12. Global Intravenous Injection Immunoglobulin Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Intravenous Injection Immunoglobulin Average Price (US$/ml) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Intravenous Injection Immunoglobulin Sales Sites and Area Served
Table 16. Manufacturers Intravenous Injection Immunoglobulin Product Types
Table 17. Global Intravenous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Injection Immunoglobulin as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Intravenous Injection Immunoglobulin Players
Table 21. Global Intravenous Injection Immunoglobulin Sales (L) by Region (2015-2020)
Table 22. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 23. Global Intravenous Injection Immunoglobulin Revenue (Million US$) by Region (2015-2020)
Table 24. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 25. North America Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 26. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 27. North America Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 29. Europe Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 30. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 31. Europe Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2015-2020) (L)
Table 34. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 37. Latin America Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 38. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 39. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 42. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 45. Global Intravenous Injection Immunoglobulin Sales (L) by Type (2015-2020)
Table 46. Global Intravenous Injection Immunoglobulin Sales Share by Type (2015-2020)
Table 47. Global Intravenous Injection Immunoglobulin Revenue (Million US$) by Type (2015-2020)
Table 48. Global Intravenous Injection Immunoglobulin Revenue Share by Type (2015-2020)
Table 49. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Type (2015-2020)
Table 50. Global Intravenous Injection Immunoglobulin Sales (L) by Application (2015-2020)
Table 51. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 52. Global Intravenous Injection Immunoglobulin Sales Growth Rate by Application (2015-2020)
Table 53. Boya-Bio Intravenous Injection Immunoglobulin Corporation Information
Table 54. Boya-Bio Description and Business Overview
Table 55. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 56. Boya-Bio Main Product
Table 57. Boya-Bio Recent Development
Table 58. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Corporation Information
Table 59. Beijing Tiantan Biological Products Corporation Information
Table 60. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 61. Beijing Tiantan Biological Products Main Product
Table 62. Beijing Tiantan Biological Products Recent Development
Table 63. Hualan Bio Intravenous Injection Immunoglobulin Corporation Information
Table 64. Hualan Bio Corporation Information
Table 65. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 66. Hualan Bio Main Product
Table 67. Hualan Bio Recent Development
Table 68. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Corporation Information
Table 69. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 70. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 71. Guangdong Shuagnlin Bio-pharmacy Main Product
Table 72. Guangdong Shuagnlin Bio-pharmacy Recent Development
Table 73. Weiguang Biological Intravenous Injection Immunoglobulin Corporation Information
Table 74. Weiguang Biological Corporation Information
Table 75. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 76. Weiguang Biological Main Product
Table 77. Weiguang Biological Recent Development
Table 78. Sinopharm Intravenous Injection Immunoglobulin Corporation Information
Table 79. Sinopharm Corporation Information
Table 80. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 81. Sinopharm Main Product
Table 82. Sinopharm Recent Development
Table 83. Shanghai RAAS Intravenous Injection Immunoglobulin Corporation Information
Table 84. Shanghai RAAS Corporation Information
Table 85. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 86. Shanghai RAAS Main Product
Table 87. Shanghai RAAS Recent Development
Table 88. CTBB Intravenous Injection Immunoglobulin Corporation Information
Table 89. CTBB Corporation Information
Table 90. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 91. CTBB Main Product
Table 92. CTBB Recent Development
Table 93. Nanyue Biopharming Intravenous Injection Immunoglobulin Corporation Information
Table 94. Nanyue Biopharming Corporation Information
Table 95. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 96. Nanyue Biopharming Main Product
Table 97. Nanyue Biopharming Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Intravenous Injection Immunoglobulin Distributors List
Table 101. Intravenous Injection Immunoglobulin Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Type (2021-2026)
Table 106. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Application (2021-2026)
Table 110. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Region (2021-2026)
Table 112. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Intravenous Injection Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Intravenous Injection Immunoglobulin Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Global Intravenous Injection Immunoglobulin Sales (L) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Intravenous Injection Immunoglobulin Sales (L) Comparison by Application: 2020 VS 2026
Table 3. Global Intravenous Injection Immunoglobulin Market Size by Type (L) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Intravenous Injection Immunoglobulin Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Intravenous Injection Immunoglobulin Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Intravenous Injection Immunoglobulin Players to Combat Covid-19 Impact
Table 9. Global Key Intravenous Injection Immunoglobulin Manufacturers Covered in This Study
Table 10. Global Intravenous Injection Immunoglobulin Sales (L) by Manufacturers (2015-2020)
Table 11. Global Intravenous Injection Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 12. Global Intravenous Injection Immunoglobulin Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Intravenous Injection Immunoglobulin Average Price (US$/ml) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Intravenous Injection Immunoglobulin Sales Sites and Area Served
Table 16. Manufacturers Intravenous Injection Immunoglobulin Product Types
Table 17. Global Intravenous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Injection Immunoglobulin as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Intravenous Injection Immunoglobulin Players
Table 21. Global Intravenous Injection Immunoglobulin Sales (L) by Region (2015-2020)
Table 22. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 23. Global Intravenous Injection Immunoglobulin Revenue (Million US$) by Region (2015-2020)
Table 24. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 25. North America Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 26. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 27. North America Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 29. Europe Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 30. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 31. Europe Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Intravenous Injection Immunoglobulin Sales by Region (2015-2020) (L)
Table 34. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Intravenous Injection Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 37. Latin America Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 38. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 39. Latin America Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2015-2020) (L)
Table 42. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Intravenous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 45. Global Intravenous Injection Immunoglobulin Sales (L) by Type (2015-2020)
Table 46. Global Intravenous Injection Immunoglobulin Sales Share by Type (2015-2020)
Table 47. Global Intravenous Injection Immunoglobulin Revenue (Million US$) by Type (2015-2020)
Table 48. Global Intravenous Injection Immunoglobulin Revenue Share by Type (2015-2020)
Table 49. Global Intravenous Injection Immunoglobulin Price (US$/ml) by Type (2015-2020)
Table 50. Global Intravenous Injection Immunoglobulin Sales (L) by Application (2015-2020)
Table 51. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 52. Global Intravenous Injection Immunoglobulin Sales Growth Rate by Application (2015-2020)
Table 53. Boya-Bio Intravenous Injection Immunoglobulin Corporation Information
Table 54. Boya-Bio Description and Business Overview
Table 55. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 56. Boya-Bio Main Product
Table 57. Boya-Bio Recent Development
Table 58. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Corporation Information
Table 59. Beijing Tiantan Biological Products Corporation Information
Table 60. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 61. Beijing Tiantan Biological Products Main Product
Table 62. Beijing Tiantan Biological Products Recent Development
Table 63. Hualan Bio Intravenous Injection Immunoglobulin Corporation Information
Table 64. Hualan Bio Corporation Information
Table 65. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 66. Hualan Bio Main Product
Table 67. Hualan Bio Recent Development
Table 68. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Corporation Information
Table 69. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 70. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 71. Guangdong Shuagnlin Bio-pharmacy Main Product
Table 72. Guangdong Shuagnlin Bio-pharmacy Recent Development
Table 73. Weiguang Biological Intravenous Injection Immunoglobulin Corporation Information
Table 74. Weiguang Biological Corporation Information
Table 75. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 76. Weiguang Biological Main Product
Table 77. Weiguang Biological Recent Development
Table 78. Sinopharm Intravenous Injection Immunoglobulin Corporation Information
Table 79. Sinopharm Corporation Information
Table 80. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 81. Sinopharm Main Product
Table 82. Sinopharm Recent Development
Table 83. Shanghai RAAS Intravenous Injection Immunoglobulin Corporation Information
Table 84. Shanghai RAAS Corporation Information
Table 85. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 86. Shanghai RAAS Main Product
Table 87. Shanghai RAAS Recent Development
Table 88. CTBB Intravenous Injection Immunoglobulin Corporation Information
Table 89. CTBB Corporation Information
Table 90. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 91. CTBB Main Product
Table 92. CTBB Recent Development
Table 93. Nanyue Biopharming Intravenous Injection Immunoglobulin Corporation Information
Table 94. Nanyue Biopharming Corporation Information
Table 95. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (Million US$), Price (US$/ml) and Gross Margin (2015-2020)
Table 96. Nanyue Biopharming Main Product
Table 97. Nanyue Biopharming Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Intravenous Injection Immunoglobulin Distributors List
Table 101. Intravenous Injection Immunoglobulin Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Type (2021-2026)
Table 106. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Application (2021-2026)
Table 110. Global Intravenous Injection Immunoglobulin Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Intravenous Injection Immunoglobulin Sales (L) Forecast by Region (2021-2026)
Table 112. Global Intravenous Injection Immunoglobulin Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Intravenous Injection Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Intravenous Injection Immunoglobulin Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Intravenous Injection Immunoglobulin
Figure 2. Global Intravenous Injection Immunoglobulin Sales Market Share by Type: 2020 VS 2026
Figure 3. 1g/20ml Product Picture
Figure 4. 1.25g/25ml Product Picture
Figure 5. 2.5g/50ml Product Picture
Figure 6. 5g/100ml Product Picture
Figure 7. 10g/200ml Product Picture
Figure 8. Global Intravenous Injection Immunoglobulin Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Intravenous Injection Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 13. Global Intravenous Injection Immunoglobulin Sales Capacity (L) (2015-2026)
Figure 14. Global Intravenous Injection Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Intravenous Injection Immunoglobulin Sales Share by Manufacturers in 2020
Figure 16. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Intravenous Injection Immunoglobulin Revenue in 2019
Figure 18. Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 20. Global Intravenous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 21. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 22. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 23. North America Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 24. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 25. U.S. Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 26. U.S. Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 28. Canada Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 30. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 31. Germany Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 32. Germany Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 34. France Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 36. U.K. Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 38. Italy Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 40. Russia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 42. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 43. China Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 44. China Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 46. Japan Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 48. South Korea Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 50. India Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 52. Australia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 54. Taiwan Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 56. Indonesia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 58. Thailand Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 60. Malaysia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 62. Philippines Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 64. Vietnam Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 66. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 67. Mexico Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 68. Mexico Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 70. Brazil Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 72. Argentina Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 75. Turkey Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 76. Turkey Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 78. Saudi Arabia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. UAE Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 80. UAE Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Intravenous Injection Immunoglobulin by Type (2015-2020)
Figure 82. Sales Market Share of Intravenous Injection Immunoglobulin by Type in 2019
Figure 83. Revenue Share of Intravenous Injection Immunoglobulin by Type (2015-2020)
Figure 84. Revenue Market Share of Intravenous Injection Immunoglobulin by Type in 2019
Figure 85. Global Intravenous Injection Immunoglobulin Sales Growth by Type (2015-2020) (L)
Figure 86. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 87. Global Intravenous Injection Immunoglobulin Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Intravenous Injection Immunoglobulin by Application (2015-2020)
Figure 89. Global Revenue Share of Intravenous Injection Immunoglobulin by Application in 2020
Figure 90. Boya-Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Beijing Tiantan Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Guangdong Shuagnlin Bio-pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Weiguang Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. CTBB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Nanyue Biopharming Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Intravenous Injection Immunoglobulin
Figure 101. Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
Figure 102. Intravenous Injection Immunoglobulin Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 107. North America Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Figure 1. Picture of Intravenous Injection Immunoglobulin
Figure 2. Global Intravenous Injection Immunoglobulin Sales Market Share by Type: 2020 VS 2026
Figure 3. 1g/20ml Product Picture
Figure 4. 1.25g/25ml Product Picture
Figure 5. 2.5g/50ml Product Picture
Figure 6. 5g/100ml Product Picture
Figure 7. 10g/200ml Product Picture
Figure 8. Global Intravenous Injection Immunoglobulin Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Intravenous Injection Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 13. Global Intravenous Injection Immunoglobulin Sales Capacity (L) (2015-2026)
Figure 14. Global Intravenous Injection Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Intravenous Injection Immunoglobulin Sales Share by Manufacturers in 2020
Figure 16. Global Intravenous Injection Immunoglobulin Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Intravenous Injection Immunoglobulin Revenue in 2019
Figure 18. Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 20. Global Intravenous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 21. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 22. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 23. North America Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 24. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 25. U.S. Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 26. U.S. Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 28. Canada Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 30. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 31. Germany Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 32. Germany Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 34. France Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 36. U.K. Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 38. Italy Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 40. Russia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 42. Asia Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 43. China Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 44. China Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 46. Japan Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 48. South Korea Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 50. India Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 52. Australia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 54. Taiwan Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 56. Indonesia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 58. Thailand Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 60. Malaysia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 62. Philippines Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 64. Vietnam Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 66. Latin America Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 67. Mexico Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 68. Mexico Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 70. Brazil Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 72. Argentina Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 75. Turkey Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 76. Turkey Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 78. Saudi Arabia Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. UAE Intravenous Injection Immunoglobulin Sales Growth Rate (2015-2020) (L)
Figure 80. UAE Intravenous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Intravenous Injection Immunoglobulin by Type (2015-2020)
Figure 82. Sales Market Share of Intravenous Injection Immunoglobulin by Type in 2019
Figure 83. Revenue Share of Intravenous Injection Immunoglobulin by Type (2015-2020)
Figure 84. Revenue Market Share of Intravenous Injection Immunoglobulin by Type in 2019
Figure 85. Global Intravenous Injection Immunoglobulin Sales Growth by Type (2015-2020) (L)
Figure 86. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 87. Global Intravenous Injection Immunoglobulin Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Intravenous Injection Immunoglobulin by Application (2015-2020)
Figure 89. Global Revenue Share of Intravenous Injection Immunoglobulin by Application in 2020
Figure 90. Boya-Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Beijing Tiantan Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Guangdong Shuagnlin Bio-pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Weiguang Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. CTBB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Nanyue Biopharming Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Intravenous Injection Immunoglobulin
Figure 101. Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
Figure 102. Intravenous Injection Immunoglobulin Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 107. North America Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Intravenous Injection Immunoglobulin Sales (L) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Intravenous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
